MetLife Investment Management’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,618
Closed -$110K 2512
2021
Q3
$110K Buy
8,618
+6,165
+251% +$83.6K ﹤0.01% 2401
2021
Q2
$40K Sell
2,453
-6,987
-74% -$122K ﹤0.01% 2427
2021
Q1
$187K Buy
9,440
+4,489
+91% +$101K ﹤0.01% 2096
2020
Q4
$102K Buy
4,951
+687
+16% +$13.1K ﹤0.01% 2222
2020
Q3
$72.9K Sell
4,264
-5,009
-54% -$100K ﹤0.01% 2253
2020
Q2
$215K Buy
+9,273
New +$204K ﹤0.01% 1864
2018
Q3
Sell
-7,388
Closed -$115K 2613
2018
Q2
$115K Hold
7,388
﹤0.01% 2155
2018
Q1
$158K Buy
+7,388
New +$103K ﹤0.01% 2012

Other funds holding DRRX

MetLife Investment Management's DRRX Position: Q4 2021 in Review

MetLife Investment Management sold out of DURECT Corp (DRRX) in Q4 2021, closing a stake of 8,618 shares — an estimated $110K sold.

MetLife Investment Management first reported a position in DRRX in Q1 2018 and held it in 8 quarters. The position peaked at $215K in Q2 2020. 101 funds tracked by Wall St. Rank hold DRRX as of Q4 2021.

  • MetLife Investment Management reported no remaining DURECT Corp position as of Q4 2021 after selling out during the quarter.
  • MetLife Investment Management sold 8,618 DURECT Corp shares in Q4 2021, an estimated $110K.
  • MetLife Investment Management first reported a position in DURECT Corp in Q1 2018 and held it in 8 quarters.
  • MetLife Investment Management's DURECT Corp position peaked at $215K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held DURECT Corp as of Q4 2021.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.